News | January 12, 2009

Cardima to Exhibit, Host Symposium at 45th Annual STS Meeting

January 13, 2009 - Cardima Inc. plans to showcase its atrial fibrillation treatment products and technologies at the 45th Annual Meeting of the Society of Thoracic Surgeons (STS) conference Jan. 26-28, 2009 in San Francisco.

Cardima will also sponsor a breakfast symposium at the STS conference entitled, "Surgical Ablation - Keys to Success." The symposium will highlight Cardima's Surgical Ablation System and feature prominent speakers including:

- Li Poa, M.D., FACS, chief of Cardiothoracic Surgery and Cardiac Surgery Program Director at Stamford Hospital and faculty member of Columbia University. Dr. Poa is among the world's leading authorities on surgical ablation for the treatment of atrial fibrillation (AF) and is head of the Cardima Center of Excellence and Training Program at Stamford Hospital. He has conducted extensive work perfecting thoracoscopic surgical techniques, and will train cardiothoracic surgeons in the use of the Cardima Surgical Ablation System.

- Sanjeev Saksena, M.D., FHRS, FACC, FESC FAHA, clinical professor of Medicine, Robert Wood Johnson School of Medicine and medical director of the Electrophysiology Research Foundation. Dr. Saksena was the director of the Cardiovascular Institute, Atlantic Health System (Eastern Campus) from 1999-2004 and is a past president of the North American Society of Pacing and Electrophysiology (NASPE). He is the founding editor and current editor-in-chief of the Journal of Interventional Cardiac Electrophysiology. Dr. Saksena is also a Planning/Steering Committee member of the National Institute of Health AFFIRM & TOPCAT trials that have focused on atrial fibrillation.

The Surgical Ablation System uses Cardima's patented technology for the ablation of cardiac tissue. The system incorporates a microcatheter-based surgical probe coupled with Cardima's INTELLITEMP, a radiofrequency energy management device. The probe incorporates irrigation, suction and illumination, which aid in placement and lesion depth. The Cardima Surgical Ablation System is reportedly able to create deep, long, linear and transmural cardiac lesions without gaps, and the small, flexible design offers sole port-hole access, potentially decreasing procedure time, patient hospital stay and discomfort.

The breakfast symposium will be held at the San Francisco Marriott on Jan. 27 at 6:00 a.m. For additional details, please contact Dilyana Hadjeva at [email protected] About Cardima Surgical Ablation System

For more information: www.Cardima.com

Related Content

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems| December 08, 2017
December 7, 2017 — Stereotaxis Inc.
CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems| October 10, 2017
October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur Ball
The Apama Radiofrequency (RF) Balloon Catheter System.
News | Ablation Systems| October 02, 2017
October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems| May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems| May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems| February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
CardioFocus, HeartLight Excalibur Balloon, 22nd Annual AF Symposium, atrial fibrillation, initial clinical evaluation
News | Ablation Systems| January 25, 2017
CardioFocus Inc. recently announced the initial clinical evaluation of the HeartLight Excalibur Balloon, a next-...
catheter ablations, atrial fibrillation, stroke risk, Intermountain Medical Center Heart Institute study, AHA Scientific Sessions, American Heart Association
News | Ablation Systems| November 14, 2016
Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower their long-term risk of...
Overlay Init